GTR Test Accession:
Help
GTR000613145.1
Registered in GTR:
2024-01-29
View version history
GTR000613145.1,
registered in GTR:
2024-01-29
Last annual review date for the lab: 2024-05-28
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Monitoring
Conditions (3):
Help
Inborn disorder of purine or pyrimidine metabolism;
Dihydropyrimidine dehydrogenase deficiency;
Lesch-Nyhan syndrome
Analytes (3):
Help
Purines;
Pyrimidines;
Uric acid
Methods (1):
Help
Biochemical Genetics - Analyte: Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Target population: Help
Evaluating patients with symptoms suspicious for disorders of purine and …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Establish or confirm diagnosis
Ordering Information
Offered by:
Help
Test short name:
Help
PUPYP
Specimen Source:
Help
- Plasma
- View specimen requirements
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Dentist
- Licensed Physician
- Nurse Practitioner
- Physician Assistant
- Public Health Mandate
- Registered Nurse
Lab contact:
Help
Gisele (Gessi) Bentz Pino, MS, CGC, Certified Genetic counselor, CGC, Genetic Counselor
biochemicalgenetics@mayo.edu
1-800-533-1710
biochemicalgenetics@mayo.edu
1-800-533-1710
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
https://www.mayocliniclabs.com/test-catalog/overview/65151#Specimen
Order URL
Order URL
Test development:
Help
Test developed by laboratory (no manufacturer test name)
Informed consent required:
Help
Based on applicable state law
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test strategy
Conditions
Help
Total conditions: 3
Condition/Phenotype | Identifier |
---|
Test Targets
Analytes
Help
Total analytes: 3
Analyte | Associated Condition |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Analyte
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis;
Monitoring
Clinical utility:
Help
Establish or confirm diagnosis
View citations (2)
- Balasubramaniam S, Duley JA, Christodoulou J. Inborn errors of purine metabolism: clinical update and therapies. J Inherit Metab Dis. 2014;37(5):669-86. doi:10.1007/s10545-014-9731-6. Epub 2014 Jun 28. PMID: 24972650.
- Balasubramaniam S, Duley JA, Christodoulou J. Inborn errors of pyrimidine metabolism: clinical update and therapy. J Inherit Metab Dis. 2014;37(5):687-98. doi:10.1007/s10545-014-9742-3. Epub 2014 Jul 17. PMID: 25030255.
Target population:
Help
Evaluating patients with symptoms suspicious for disorders of purine and pyrimidine metabolism.
Monitoring patients with disorders of purine and pyrimidine metabolism.
Laboratory evaluation of primary and secondary hyperuricemias.
Assessing tolerance for fluoropyrimidine drugs used in cancer treatment.
Aiding in the diagnosis of individuals with suspected dihydropyrimidine dehydrogenase deficiency.
View citations (4)
- Balasubramaniam S, Duley JA, Christodoulou J. Inborn errors of purine metabolism: clinical update and therapies. J Inherit Metab Dis. 2014;37(5):669-86. doi:10.1007/s10545-014-9731-6. Epub 2014 Jun 28. PMID: 24972650.
- Balasubramaniam S, Duley JA, Christodoulou J. Inborn errors of pyrimidine metabolism: clinical update and therapy. J Inherit Metab Dis. 2014;37(5):687-98. doi:10.1007/s10545-014-9742-3. Epub 2014 Jul 17. PMID: 25030255.
- Knikman JE, Gelderblom H, Beijnen JH, Cats A, Guchelaar HJ, Henricks LM. Individualized Dosing of Fluoropyrimidine-Based Chemotherapy to Prevent Severe Fluoropyrimidine-Related Toxicity: What Are the Options?. Clin Pharmacol Ther. 2021;109(3):591-604. doi:10.1002/cpt.2069. Epub 2020 Nov 12. PMID: 33020924.
- Nyhan WL, Hoffmann GF, Al-Aqeel AI, Barshop BA: Introduction to the disorders of purine and pyrimidine metabolism. Atlas of Inherited Metabolic Diseases. 4th ed. CRC Press; 2020:495-495
Recommended fields not provided:
Clinical validity,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
Filtered EDTA plasma is mixed with an internal standard mixture and analyzed for uracil, thymine, adenine, hypoxanthine, xanthine, dihydroorotic, uric acid, deoxythymidine, deoxyuridine, uridine, deoxyinosine, deoxyguanosine, inosine, guanosine, dihydrouracil, dihydrothymine, N-carbamoyl- beta-alanine and N-carbamoyl- beta-aminoisobutyric acid by liquid chromatography-tandem mass spectrometry. The ratios of the extracted peak areas of the …
View more
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Recovery was used to assess accuracy; mean recovery ranged from 79%-120%. Recovery was performed on 18 analytes; clinical specificity of the assay was also used to assess accuracy and was acceptable. Intra assay precision was performed at 3 levels: CV results ranged from 2.1%-16.1% (N=20 each). Inter assay precision was …
View more
Assay limitations:
Help
Additional confirmatory testing is required for follow-up of abnormal results.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Intra-Laboratory
Description of PT method: Help
Intra-laboratory alternative assessment of performance through quality control or patient blind testing
Description of internal test validation method: Help
This test was laboratory developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements.
Yes
Method used for proficiency testing: Help
Intra-Laboratory
Description of PT method: Help
Intra-laboratory alternative assessment of performance through quality control or patient blind testing
Description of internal test validation method: Help
This test was laboratory developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements.
Recommended fields not provided:
Test Confirmation,
Citations to support assay limitations,
Citations to support internal test validation method,
Citations for Analytical validity,
PT Provider,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Reviews:
Clinical resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.